Peter Demuth News Today

Vaccines that target tumors with specific genetic mutations in pancreatic and other cancers have shown promise in early-stage trials

Published data shows lymph node-targeted Amphiphile -peptide and CpG combination with TCR-T cell therapy led to complete eradication and durable responses against established murine solid tumors...

The road to effective cancer vaccines has been long and difficult. Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleuce

At a pivotal moment in cancer vaccine research, the MIT Koch Institute Annual Symposium explored emerging successes and obstacles in the field in areas that include immunology, next-generation tools and models, and mRNA and other vaccine platforms.

The new vaccine candidate offers a breakthrough approach that combines two powerful arms of the immune system to target Epstein–Barr virus in both acute and latent infection.

12/05/22 Life Science Leader Newsletter

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Peter DeMuth said he drove from Fargo to St. Paul on Thursday for one reason. "Because I want my vote counted," the North Dakota State University student said while testifying in the U.S. Senate election trial. DeMuth, 23, was called as a witness...